Arch Biopartners Receives Permission From U S FDA to Proceed With Phase II Acute Kidney Injury Trial tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
TORONTO, April 18, 2023 Today, Arch Biopartners Inc., , a clinical stage company focused on the development of novel therapeutics targeting organ inflammation, announced that it has safely. | April 18, 2023
Take a pass on Arch Biopartners, says Raymond James cantechletter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cantechletter.com Daily Mail and Mail on Sunday newspapers.
09.02.2022 - TORONTO, Feb. 08, 2022 (GLOBE NEWSWIRE) - Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Company has arranged a shares for debt transaction to settle an aggregate of $424,767.07 in . Seite 1
TORONTO, March 16, 2021 (GLOBE NEWSWIRE) Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company…